Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05781711

Title field or adapter rule

{'original_value': "Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease", 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:33.400238+00:00

Published At

2026-10-30T00:00:00+00:00

Record Updated At

2026-10-30

Source Retrieved At

2026-10-31T22:18:37.902788+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Parkinson Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05781711"

protocolSection.identificationModule.officialTitle

"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson\u0027s Disease"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Parkinson Disease (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Control Group', 'Metformin group'], 'description': "levodopa-carbidopa is the standard therapy used in Parkinson's disease", 'name': 'levodopa-carbidopa', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Metformin group'], 'description': 'Metformin, a biguanide family member commonly used in treatment for type 2 diabetes, appears to increase liver and peripheral tissue sensitivity to insulin as well as reduce hepatic glucose production', 'name': 'Metformin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• levodopa-carbidopa (protocolSection.armsInterventionsModule.interventions[].name)
• Metformin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.